• PDF / 188,503 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 104 Downloads / 211 Views

DOWNLOAD

REPORT

20/0861-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 5 Sep 2020 No. 861

1

Recommend Documents

Bevacizumab + capecitabine not cost effective in mCRC

162 48 111KB

Stepped Care Models

142 46 35MB

Pharmacist care cost effective for CVD prevention in diabetes

177 42 111KB

Patient-initiated DMARD self-monitoring service not cost effective

190 97 167KB

Acute care surgery: a means for providing cost-effective, quality care for gallstone pancreatitis

159 58 655KB

Vaccinating boys along with girls against HPV not cost effective

141 15 139KB

Targeted immune modulators not cost effective in ulcerative colitis

146 89 163KB

Ivacaftor not cost effective in cystic fibrosis with G551D mutation

163 21 182KB

Cost-Effective

168 109 57MB

Patient-centred care cost effective in acute coronary syndrome

157 87 182KB

Stepped Care Models in Addiction Treatment

173 63 28MB

Depression care for US prostate cancer patients: more QALYs, lower cost

140 79 163KB